HIV-ANTIGENE UND -ANTIKÖRPER
European patent · EP2961427 · In force
Register entry
- Publication number
- EP2961427
- Application number
- EP14756908
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Feb 28, 2014
- Published
- Jan 6, 2016
- Granted
- Mar 25, 2020
- Protection ends at the latest
- Feb 27, 2034
- Next annual fee due
- Feb 28, 2027
- IPC classes
- A61K 39/395 (2006.01)
- Priority
- US 201361770974 P 28.02.2013
- PCT application
- PCT/US2014/019612 28.02.2014
- PCT publication
- WO2014/134547 04.09.2014
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 1, 2026
Change
Published in Swissreg on 01.03.2026
- Mar 1, 2025
Change
Published in Swissreg on 01.03.2025
- Mar 1, 2024
Change
Published in Swissreg on 01.03.2024
- Mar 6, 2023
Change
Published in Swissreg on 06.03.2023
- Apr 16, 2020
Agent entered
- Representative
- TR-IP Consulting LLC, Route du Coutset 18, 1485 Nuvilly
Published in Swissreg on 16.04.2020
- Mar 25, 2020
Granted
Published in Swissreg on 25.03.2020
Parties
Inventor
KILLIAN, M., Scott
San Francisco, CA 94116, US
VYAS, Girish
San Francisco, CA 94116, US
SZAKAL, Evelin
San Francisco, CA 94116, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.